Building rings with spheres: a cell therapy approach to incontinence

M Gilbert, S Čaputová, D Poli et al

07 December 2023

Commentary

An update on prime editing: recent advances and applications

Karl Petri, Julian Grünewald

23 November 2023

Commentary

Unravelling immunogenicity induced by Cas9 in gene therapy: a comprehensive commentary of current understanding and implications

Anna Lina Cavallo

08 November 2023

Commentary

Unraveling the origins of human adeno-associated virus 5

Robert J Gifford, Robert M Kotin

14 June 2023

Commentary

A winning combination in the war against deadly cancers: exploring new opportunities for combining antibody–drug conjugates and cancer immunotherapies

Rakesh Dixit

20 April 2022

Commentary

Cancer immunotherapy & clinical trial design: issues & practice

Janet E Dancey, MD, FRCPC

30 March 2022

Commentary

Therapeutic mRNA delivery with targeted lipid nanoparticles: next-generation transformative medicines

Umar Iqbal, Jagdeep K Sandhu

27 March 2022

Commentary

Raiders of the lost art: finding immuno-oncology treasure

Kishore K Gangangari, Anthony Murphy, Reni Benjamin

21 March 2022

Commentary

BCMA targeting CAR T cells using a novel D-domain binder for multiple myeloma: clinical development update

A Rotte, C Heery, B Gliner et al

24 January 2022

Commentary

Yes, IMMUcan! Unraveling the human tumor microenvironment

Henoch Hong, Robin Liechti, Marie Morfouace

14 October 2021

Commentary

Cancer in 4D: the importance of spatial and temporal heterogeneity through breast cancer molecular cartography

Constanza Martinez

11 October 2021

Commentary

Towards the rational design of a next-generation dendritic cell vaccine for cancer immunotherapy

Marcelo Bravo, Timothy J Davies, Paul J Fairchild

08 June 2021

Commentary

Major clinical stories and read-outs from key conferences for the cell and gene therapy space

Sven Kili

25 November 2020

Commentary

Monoclonal antibodies to enable therapeutic tolerance to stem cell derived transplants?

Herman Waldmann

23 October 2020

Commentary

Developing harmonized immune platforms: a must-have for realizing personalized therapies in solid tumors

D Morrow, J Langermans, A Ussi et al

20 October 2020

Commentary

Is a second wave of (CAR T) cell based cancer therapies a mirage or reality?

David Gilham

22 September 2020

Commentary

Chemogenetics: drug-controlled gene therapies for neural circuit disorders

Scott M Sternson, David Bleakman

08 September 2020

Commentary

Clinical trials in the era of Covid-19: successes, failures & ongoing challenges

Sven Kili

04 August 2020

Commentary

Analytical Technology Used in the Latest Development of Gene Therapy Candidates

Z Li, Z Wu, T Maekawa et al

16 May 2019

Commentary